DiscoverThe Rounds TableEpisode 125 - Top Papers from the 2025 American Diabetes Association (ADA) Session
Episode 125 - Top Papers from the 2025 American Diabetes Association (ADA) Session

Episode 125 - Top Papers from the 2025 American Diabetes Association (ADA) Session

Update: 2025-07-03
Share

Description

Send us a text

Welcome back Rounds Table Listeners! We are back today with a special Rapid Fire Podcast. This week, Dr. Mike Fralick and guest host Danielle Cutler discuss the top papers from the 2025 American Diabetes Association (ADA) Scientific Session. Hot off the presses, here we go!

  1. Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial (0:00 - 6:05 )
  2. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes (6:06 - 13:22 )
  3. Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (13:23 - 20:35 )

The Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 125 - Top Papers from the 2025 American Diabetes Association (ADA) Session

Episode 125 - Top Papers from the 2025 American Diabetes Association (ADA) Session

Dr. John Fralick and Dr. Michael Fralick